Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Goodman

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 26, 2024
Alterations in adolescent brain serotonin (5HT)<sub>1A</sub>, 5HT<sub>2A</sub>, and dopamine (D)<sub>2</sub> receptor systems in a nonhuman primate model of early life adversityAlison G P Wakeford, Jonathon A Nye, Elyse L Morin, et al.
Cancer|July 1, 2011
Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemiaJorge Cortes, Hagop Kantarjian, Edward D Ball, et al.
Blood|May 6, 2003
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trialsSergio Giralt, William Bensinger, Mark Goodman, et al.
American Journal of Hematology|December 15, 2015
Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?Germán Campuzano-Zuluaga, Yehuda Deutsch, Matthew Salzberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myelomaNizar J Bahlis, Jennifer McCafferty-Grad, Ileana Jordan-McMurry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2016
Impact of <sup>18</sup>F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized TrialAshesh B Jani, Eduard Schreibmann, Peter J Rossi, et al.
Angewandte Chemie (International Ed. in English)|October 22, 2014
PET imaging of bacterial infections with fluorine-18-labeled maltohexaoseXinghai Ning, Wonewoo Seo, Seungjun Lee, et al.
Blood Advances|July 6, 2022
Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplantAntonio Jimenez Jimenez, Krishna Komanduri, Samantha Brown, et al.
Bone Marrow Transplantation|June 29, 2026
False-positive HIV-1 RNA detection following obecabtagene autoleucelJose F Camargo, Anthony D Anderson, Jay Spiegel, et al.
Transplantation and Cellular Therapy|September 20, 2021
Lower Incidence of Cytomegalovirus Reactivation Following Post-Transplantation Cyclophosphamide HLA-Mismatched Unrelated Donor TransplantationJose F Camargo, Yosuke Ebisu, Antonio Jimenez-Jimenez, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 26, 2024
Alterations in adolescent brain serotonin (5HT)<sub>1A</sub>, 5HT<sub>2A</sub>, and dopamine (D)<sub>2</sub> receptor systems in a nonhuman primate model of early life adversityAlison G P Wakeford, Jonathon A Nye, Elyse L Morin, et al.
Cancer|July 1, 2011
Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemiaJorge Cortes, Hagop Kantarjian, Edward D Ball, et al.
Blood|May 6, 2003
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trialsSergio Giralt, William Bensinger, Mark Goodman, et al.
American Journal of Hematology|December 15, 2015
Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?Germán Campuzano-Zuluaga, Yehuda Deutsch, Matthew Salzberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myelomaNizar J Bahlis, Jennifer McCafferty-Grad, Ileana Jordan-McMurry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2016
Impact of <sup>18</sup>F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized TrialAshesh B Jani, Eduard Schreibmann, Peter J Rossi, et al.
Angewandte Chemie (International Ed. in English)|October 22, 2014
PET imaging of bacterial infections with fluorine-18-labeled maltohexaoseXinghai Ning, Wonewoo Seo, Seungjun Lee, et al.
Blood Advances|July 6, 2022
Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplantAntonio Jimenez Jimenez, Krishna Komanduri, Samantha Brown, et al.
Bone Marrow Transplantation|June 29, 2026
False-positive HIV-1 RNA detection following obecabtagene autoleucelJose F Camargo, Anthony D Anderson, Jay Spiegel, et al.
Transplantation and Cellular Therapy|September 20, 2021
Lower Incidence of Cytomegalovirus Reactivation Following Post-Transplantation Cyclophosphamide HLA-Mismatched Unrelated Donor TransplantationJose F Camargo, Yosuke Ebisu, Antonio Jimenez-Jimenez, et al.
Pageof 6